Hashtag
#srt
Advertisement · 728 × 90
@shionogiincus.bsky.social announced via news release that the first patients have been enrolled in a global phase 2 #ClinicalTrial evaluating S-606001, an investigational oral substrate reduction therapy (#SRT) for late-onset #PompeDisease.
Read more: https://bit.ly/480ixVB
#RareDisease #MedSky
2
0
0
0